India to Belgium: Albendazole Export Trade Route
India has recorded 230 verified shipments of Albendazole exported to Belgium, representing a combined trade value of $4.0M USD. This corridor is served by 14 active Indian exporters, with an average shipment value of $17.6K USD. The leading Indian exporter is GRACURE PHARMACEUTICALS LIMITED, which accounts for 60% of total export value with 125 shipments worth $2.4M USD. On the buying side, NA is the largest importer in Belgium with $3.6M USD in purchases. The top 3 suppliers — GRACURE PHARMACEUTICALS LIMITED, GRACURE PHARMACEUTICALS LIMITED , MEDOPHARM — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Belgium Albendazole corridor is one of India's established pharmaceutical export routes, with 230 shipments documented worth a combined $4.0M USD. The route is dominated by GRACURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's albendazole manufacturing sector.
Across 14 active suppliers, the average shipment value stands at $17.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with albendazole's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 30.4%, placing it at rank #18 among India's top albendazole export destinations globally.
On the import side, key buyers of Indian albendazole in Belgium include NA, EXPHAR SANIVELLES SUD ZONE II THINES, MSF SUPPLY ASBL and 16 others. NA is the single largest importer with 138 shipments valued at $3.6M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ3
- Primary modeSea freight
- Top portPATLI ICD
Market Position
- Global rank#18
- Annual growth+30.4%
- Demand growth+27.2%
- Regulatory ease85/100
Top 10 Indian Albendazole Exporters to Belgium
Showing top 10 of 14 Indian suppliers exporting Albendazole to Belgium, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GRACURE PHARMACEUTICALS LIMITED Avg $19.4K per shipment | 125 | $2.4M | 60.0% |
| 2 | GRACURE PHARMACEUTICALS LIMITED Avg $45.7K per shipment | 32 | $1.5M | 36.1% |
| 3 | MEDOPHARM Avg $13.4K per shipment | 6 | $80.6K | 2.0% |
| 4 | MEDOPHARM Avg $17.9K per shipment | 2 | $35.7K | 0.9% |
| 5 | VINCCENT BIOTECH PRIVATE LIMITED Avg $15.8K per shipment | 2 | $31.6K | 0.8% |
| 6 | VINCCENT BIOTECH PRIVATE LIMITED Avg $6.6K per shipment | 1 | $6.6K | 0.2% |
| 7 | MOVID IMPEX Avg $3 per shipment | 33 | $101 | 0.0% |
| 8 | LAWRENCE WALTER Avg $11 per shipment | 7 | $75 | 0.0% |
| 9 | LAWRENCE WALTER Avg $12 per shipment | 4 | $49 | 0.0% |
| 10 | EASYSHIP FULFILLMENT PRIVATE LIMITED Avg $4 per shipment | 11 | $39 | 0.0% |
This table shows the top 10 of 14 Indian companies exporting albendazole to Belgium, ranked by total trade value. The listed exporters are: GRACURE PHARMACEUTICALS LIMITED, GRACURE PHARMACEUTICALS LIMITED , MEDOPHARM, MEDOPHARM , VINCCENT BIOTECH PRIVATE LIMITED, VINCCENT BIOTECH PRIVATE LIMITED , MOVID IMPEX, LAWRENCE WALTER, LAWRENCE WALTER , EASYSHIP FULFILLMENT PRIVATE LIMITED. GRACURE PHARMACEUTICALS LIMITED is the dominant supplier with 125 shipments worth $2.4M USD, giving it a 60% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Showing top 10 of 14 total Indian exporters on the India to Belgium Albendazole export route.
Top 10 Albendazole Importers in Belgium
Showing top 10 of 19 known buyers in Belgium receiving Albendazole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian albendazole in Belgium include NA, EXPHAR SANIVELLES SUD ZONE II THINES, MSF SUPPLY ASBL, TEDIS, MSF SUPPLY STOCK, among 19 total buyers. The largest importer is NA, accounting for $3.6M USD across 138 shipments — representing 89% of all albendazole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NA | 138 | $3.6M | 89.0% |
| 2 | EXPHAR SANIVELLES SUD ZONE II THINES | 18 | $268.6K | 6.6% |
| 3 | MSF SUPPLY ASBL | 4 | $57.5K | 1.4% |
| 4 | TEDIS | 2 | $31.6K | 0.8% |
| 5 | MSF SUPPLY STOCK | 2 | $23.1K | 0.6% |
| 6 | TO THE ORDER | 1 | $22.5K | 0.6% |
| 7 | MSF SUPPLY STOCK | 1 | $17.9K | 0.4% |
| 8 | MSF SUPPLY C/O DSV AIR & SEA NV | 1 | $17.8K | 0.4% |
| 9 | TEDIS | 1 | $6.6K | 0.2% |
| 10 | BPOST INTERNATIONAL | 36 | $152 | 0.0% |
Showing top 10 of 19 Albendazole importers in Belgium on this route.
Top 10 Albendazole Formulations Imported by Belgium
Showing top 10 of 119 product formulations shipped on the India to Belgium Albendazole route, ranked by trade value
Belgium imports a wide range of albendazole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — VERZOL SUSPENSION B/10 ML (ALBENDAZOLE U — accounts for $993.2K USD across 22 shipments. There are 119 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | VERZOL SUSPENSION B/10 ML (ALBENDAZOLE U | 22 | $993.2K | 24.5% |
| 2 | VERZOL SUSPENSION B/10 ML (ALBENDAZOLE USP 200MG/5ML) | 13 | $558.1K | 13.8% |
| 3 | VERZOL TABLETS B/1 ( ALBENDAZOLE TABLETS | 9 | $415.9K | 10.3% |
| 4 | VERZOL SUSPENSION B 10 ML ALBENDAZOLE USP 200MG 5ML | 7 | $290.2K | 7.2% |
| 5 | VERZOL TABLETS B/1 ( ALBENDAZOLE TABLETS400 MG ) | 3 | $131.6K | 3.3% |
| 6 | VERZOL TABLETS B 1 ALBENDAZOLE TABLETS400 MG | 2 | $92.5K | 2.3% |
| 7 | VERZOL TABLETS B/1( ALBENDAZOLE TABLETS | 1 | $92.4K | 2.3% |
| 8 | VERZOL SUSPENSION B/10 ML(ALBENDAZOLE USP 200MG/5ML) B.NO.AS240013A, MFG.DT.01/2024, EXP.DT.12/2026197200NOS | 6 | $84.8K | 2.1% |
| 9 | VERZOL SUSPENSION B/10 ML(ALBENDAZOLE USP 200MG/5ML)B.NO.AS240068A,AS240069A, MFG.DT.02/2024, EXP.DT.01/2027 | 1 | $83.8K | 2.1% |
| 10 | VERZOL TABLETS B/1ALBENDAZOLE TABLETS 400 MGB.NO.AT230637A M.D.10/2023 EXP.DT.09/2023 | 1 | $46.4K | 1.1% |
Showing top 10 of 119 Albendazole formulations imported by Belgium on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
PATLI ICD handles the highest volume with 53 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's albendazole exports to Belgium are driven primarily by a handful of large-scale manufacturers. GRACURE PHARMACEUTICALS LIMITED with 125 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 14 active exporters signals a competitive but concentrated market — buyers in Belgium benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GRACURE PHARMACEUTICALS LIMITED, GRACURE PHARMACEUTICALS LIMITED , MEDOPHARM — together account for 98% of total trade value on this route. The average shipment value of $17.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as verzol suspension b/10 ml (albendazole usp 200mg/5ml) and verzol tablets b/1 ( albendazole tablets , suggesting that buyers in Belgium tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NA is the largest importer with 138 shipments worth $3.6M USD — representing 89% of all albendazole imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.0M
- Avg. Shipment
- $17.6K
- Suppliers
- 14
- Buyers
- 19
- Transit (Sea)
- ~17 days
- Annual Growth
- +30.4%
Related Analysis
Other Albendazole Routes
Unlock the Full India to Belgium Albendazole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 230 shipments on this route.
Live Corridor Intelligence
India → Belgium trade corridor intelligence
1Live Corridor Intelligence
As of March 2026, the India-Belgium pharmaceutical trade corridor is experiencing significant disruptions due to escalating geopolitical tensions in the Middle East. Heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor have led major carriers to suspend or restrict transits, resulting in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes. These disruptions have been particularly impactful on time-sensitive pharmaceutical exports, including formulations containing Albendazole.
Currency fluctuations have also affected trade dynamics. The Indian Rupee (INR) has depreciated against the Euro (EUR) over the past year, influencing the cost competitiveness of Indian pharmaceutical exports to Belgium. Additionally, the implementation of the India–European Union Free Trade Agreement (FTA) in January 2026 has introduced new tariff structures, necessitating adjustments in pricing and supply chain strategies for exporters.
Geopolitical & Sanctions Impact
India → Belgium trade corridor intelligence
1Geopolitical & Sanctions Impact
The ongoing conflicts in the Middle East, notably the Israel-Iran 12-Day War in June 2025, have had a profound impact on global shipping routes. The conflict led to extreme GPS and AIS signal jamming in the Strait of Hormuz, making safe navigation nearly impossible without military escorts. This situation triggered an immediate surge in war-risk insurance premiums, adding approximately $10 per barrel to fuel costs, which directly translated into higher freight rates for bulk carriers, including those transporting pharmaceuticals.
Furthermore, the rerouting of vessels around the Cape of Good Hope has increased transit times and operational costs. These geopolitical tensions have introduced volatility in freight rates and insurance premiums, posing challenges for Indian pharmaceutical exporters relying on the India-Belgium trade corridor.
Trade Agreement & Policy Analysis
India → Belgium trade corridor intelligence
1Trade Agreement & Policy Analysis
The India–European Union Free Trade Agreement (FTA), signed on January 27, 2026, aims to eliminate or reduce tariffs on the majority of goods traded between India and the EU, including pharmaceutical products. While the agreement is subject to legal vetting and translation before formal implementation, it is expected to significantly enhance trade relations by providing preferential market access and reducing trade barriers. However, specific product-level schedules and legally binding commitments are anticipated to be clarified following the publication of the treaty text and associated annexes.
Additionally, the India–EFTA Trade and Economic Partnership Agreement (TEPA), which entered into force on October 1, 2025, includes commitments on sustainable development and an investment pledge of $100 billion from the EFTA side to India over 15 years. This agreement is expected to boost India's exports of products such as pharmaceuticals to the EFTA region.
Landed Cost Breakdown
India → Belgium trade corridor intelligence
1Landed Cost Breakdown
Estimating the landed cost components for Albendazole formulations shipped from India to Belgium involves several factors:
- FOB Price: The Free on Board (FOB) price for Albendazole formulations varies depending on the manufacturer and product specifications. For instance, GRACURE PHARMACEUTICALS LIMITED reported exports totaling $2.4 million, indicating a substantial share in the market.
- Sea Freight Cost per Container: Due to recent disruptions, freight rates have increased by 40–50%. Assuming a pre-disruption rate of $2,000 per 20-foot container, current rates would range between $2,800 and $3,000.
- Insurance: War-risk insurance premiums have surged, adding approximately $10 per barrel to fuel costs. This increase translates into higher insurance costs for shipments, potentially adding $500–$1,000 per container.
- Customs Duty: Under the new India–EU FTA, many pharmaceutical products are expected to benefit from reduced or eliminated tariffs. However, specific duty rates for Albendazole formulations will depend on the final tariff schedules published in the agreement.
- Clearance Charges: Customs clearance charges in Belgium typically range from €100 to €200 per shipment, depending on the complexity and volume of goods.
- VAT/GST: Belgium imposes a Value Added Tax (VAT) of 21% on imported goods. However, pharmaceutical products may be subject to reduced rates or exemptions, necessitating consultation with Belgian customs authorities for precise rates.
- Local Distribution: Costs associated with local distribution, including warehousing and transportation within Belgium, can vary widely but are estimated at €500–€1,000 per shipment, depending on the distribution network and distance to end-users.
In summary, the total landed cost per container for Albendazole formulations from India to Belgium has increased due to higher freight and insurance costs stemming from geopolitical tensions. Exporters must also consider the implications of the new India–EU FTA on customs duties and ensure compliance with local VAT regulations to accurately calculate the total landed cost.
Belgium Pharmaceutical Import Regulations
EMA registration, GMP, and compliance requirements for Indian exporters
1EMA Registration & Import Requirements
To import Albendazole formulations into Belgium, the product must possess a valid marketing authorization. Applicants are required to submit a comprehensive dossier in the Common Technical Document (CTD) or electronic CTD (eCTD) format, encompassing quality, safety, and efficacy data. The approval timeline varies based on the completeness of the submission and the specific regulatory pathway chosen. While exact product registration fees are not specified, they are determined by the EMA and may vary depending on the application type.
Manufacturing facilities in India producing Albendazole formulations intended for the Belgian market must comply with Good Manufacturing Practice (GMP) standards recognized by the EMA. These facilities are subject to GMP inspections to ensure compliance with EU regulations. The EMA's "Quality systems framework for GMP inspectorates" outlines the requirements for such inspections, emphasizing the importance of mutual recognition and administrative collaboration between member states. (ema.europa.eu)
2Quality & GMP Standards for Indian Exporters
Indian exporters of Albendazole formulations must hold GMP certifications that align with EU standards. The EMA recognizes GMP certificates issued by competent authorities of countries with which the EU has a Mutual Recognition Agreement (MRA). However, India is not currently part of such an MRA with the EU, necessitating direct inspections by EU authorities or their designees.
As of August 2024, the World Health Organization (WHO) prequalified Albendazole chewable tablets (400 mg) produced by Mepro Pharmaceuticals Pvt. Ltd. on August 16, 2024, and Indoco Remedies Limited on August 30, 2024. While WHO prequalification is a positive indicator of quality, it does not replace the need for EMA-recognized GMP certification for the EU market. (extranet.who.int)
Recent inspections or regulatory actions by the EMA against Indian pharmaceutical companies are not publicly detailed. However, Indian manufacturers are advised to stay informed about EMA communications and ensure continuous compliance with GMP standards to avoid potential regulatory actions.
3Recent Regulatory Developments (2024-2026)
In November 2025, the Drugs Controller General of India (DCGI) directed state drug regulators to enforce revised GMP standards under Schedule M of the Drugs and Cosmetics Act by January 2026. This initiative aims to align India's pharmaceutical manufacturing norms with global standards, potentially facilitating smoother exports to markets like Belgium.
As of March 2026, there have been no significant changes in the EU's regulatory framework specifically affecting the import of Albendazole formulations from India to Belgium. However, Indian exporters should remain vigilant for any updates to EU regulations or potential Mutual Recognition Agreements that could impact export procedures.
In summary, importing Albendazole formulations into Belgium necessitates obtaining EMA marketing authorization, ensuring manufacturing facilities comply with EU GMP standards, and staying abreast of regulatory developments both in India and the EU.
Belgium Albendazole Market Context & Tariffs
Market size, import duties, and competitive landscape
1Belgium Albendazole Market Size & Demand
Albendazole is an anthelmintic medication used to treat various parasitic infections. In Belgium, the demand for Albendazole formulations is influenced by factors such as the prevalence of parasitic infections, healthcare spending, and the country's comprehensive health coverage. While specific market size data for Albendazole in Belgium for 2024-2025 is not readily available, the global Albendazole drug market was valued at approximately $11.67 billion in 2024 and is projected to reach $12.81 billion in 2025. This indicates a growing global demand for Albendazole formulations.
Belgium's pharmaceutical industry is robust, with both domestic manufacturing and imports contributing to the availability of medications. The country imports Albendazole formulations to meet demand, with India being a significant supplier. Between August 2023 and July 2024, Belgium imported 52 shipments of Albendazole tablets, primarily from India. This underscores the reliance on imports to supplement domestic production and ensure a steady supply of Albendazole formulations.
2Import Tariff & Duty Structure
Belgium applies a 0% MFN import duty rate on pharmaceutical products classified under HS code 30049099, which includes finished Albendazole formulations. Additionally, there are no preferential rates, free trade agreement benefits, or exemptions specifically affecting pharmaceutical imports under this classification. This duty-free status facilitates the importation of Albendazole formulations into Belgium, ensuring that these essential medications are accessible without additional tariff burdens.
3Competitive Landscape
India is a major supplier of Albendazole formulations to Belgium, accounting for a significant portion of the imports. Between August 2023 and July 2024, Belgium imported 52 shipments of Albendazole tablets, primarily from India. While specific data on other supplying countries and their market shares are not detailed, India's prominence as a supplier suggests competitive pricing and established trade relationships. Comparative pricing data between India and other potential suppliers, such as China or European manufacturers, is not specified. However, India's substantial share in Belgium's Albendazole imports indicates a competitive edge, likely due to cost-effective production and established supply chains.
Supplier Due Diligence Guide — Albendazole from India
Pre-qualification checklist, document requirements, red flags, and audit guidance for Belgium buyers
1Pre-Qualification Checklist for Belgium Buyers
1. Verify Regulatory Approvals:
2. Assess Quality Management Systems:
3. Confirm Certifications and Compliance:
4. Evaluate Manufacturing Capabilities:
5. Review Financial Stability:
6. Assess Regulatory History:
2Key Documents to Request from Indian Suppliers
1. Certificate of Analysis (CoA):
2. Certificate of Origin (CoO):
3. GMP Certificate:
4. Stability Data:
5. Batch Manufacturing Records (BMR):
6. Drug Master File (DMF):
7. Free Sale Certificate:
8. Insurance Certificates:
3Red Flags & Warning Signs
1. Regulatory Non-Compliance:
2. Unrealistically Low Pricing:
3. Lack of Stability Data:
4. Limited Export Experience:
5. Resistance to Audits:
6. Inconsistent Communication:
4Factory Audit & Ongoing Monitoring
1. Pre-Audit Desktop Review:
2. On-Site Inspection Focus Areas:
3. Post-Audit Corrective Actions:
4. Annual Re-Qualification Process:
5. Remote Monitoring Options:
6. Cost Estimates and Timelines:
By meticulously following these guidelines, Belgian companies can establish robust supplier relationships with Indian manufacturers, ensuring the consistent quality and regulatory compliance of Albendazole formulations.
Frequently Asked Questions — India to Belgium Albendazole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Albendazole to Belgium?
The leading Indian exporters of Albendazole to Belgium are GRACURE PHARMACEUTICALS LIMITED, GRACURE PHARMACEUTICALS LIMITED , MEDOPHARM. GRACURE PHARMACEUTICALS LIMITED holds the largest market share at approximately 60% of total trade value on this route.
Q What is the total value of Albendazole exports from India to Belgium?
India exports Albendazole to Belgium worth approximately $4.0M USD across 230 recorded shipments. The average value per shipment is $17.6K USD.
Q Which ports does India use to ship Albendazole to Belgium?
The most active port of origin is PATLI ICD with 53 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Belgium for Albendazole?
The average transit time for Albendazole shipments from India to Belgium is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to Belgium Albendazole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.4% with demand growth tracking at 27.2%. The route is ranked #18 among India's top Albendazole export destinations globally.
Q How many suppliers are active on the India to Belgium Albendazole route?
There are currently 14 active Indian suppliers exporting Albendazole to Belgium. The market is moderately concentrated with GRACURE PHARMACEUTICALS LIMITED accounting for 60% of total shipment value.
Q Who are the main importers of Albendazole from India in Belgium?
The leading importers of Indian Albendazole in Belgium include NA, EXPHAR SANIVELLES SUD ZONE II THINES, MSF SUPPLY ASBL, TEDIS, MSF SUPPLY STOCK. NA is the largest buyer with 138 shipments worth $3.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Belgium export trade corridor identified from Indian Customs (DGFT) records for Albendazole.
- 2.Supplier/Buyer Matching: 14 Indian exporters and 19 importers in Belgium matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 230 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
230 Verified Shipments
14 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists